Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tadalafil and acetazolamide

PreclinicalSmall molecule

SSheba Medical Center

Tadalafil and acetazolamide is one of 2 small molecule programs targeting Acute Mountain Sickness. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acute Mountain SicknessCompleted

Acute Mountain SicknessPreclinical

Completed

Competition

Competitive Landscape

1 competitor in Acute Mountain Sickness

#DrugCompanyPhaseTrials

Reglan

IIstituto Clinico Humanitas

Tadalafil and acetazolamide

SSheba Medical Center

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Acute Mountain Sickness1 trial

Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention

Completed·SSheba Medical Center·N/A·NCT01060969·55 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tadalafil and acetazolamide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tadalafil and acetazolamide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tadalafil and acetazolamide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sheba Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSheba Medical Center

Related News